Impact of Anesthesia Protocols on In Vivo Bioluminescent Bacteria Imaging Results

• Published in: PloS one Vol. 10; no. 7; p. e0134048
• Main Authors: Chuzel, Thomas, Sanchez, Violette, Vandamme, Marc, Martin, Stéphane, Flety, Odile, Pager, Aurélie, Chabanel, Christophe, Magnier, Luc, Foskolos, Marie, Petit, Océane, Rokbi, Bachra, Chereul, Emmanuel
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 24.07.2015; Public Library of Science (PLoS)
• Subjects: Anesthesia; Anesthesia - methods; Anesthetics; Anesthetics, Dissociative - pharmacology; Animal models; Animals; Bacteria; Bacterial infections; Biofilms; Bioluminescence; Catheters; Critical point; Emission analysis; Emissions; Fluctuations; Flux; Health aspects; Imaging; In vivo methods and tests; Infection; Isoflurane; Isoflurane - pharmacology; Ketamine; Ketamine - pharmacology; Kinetics; Luciferase; Luminescent Measurements; Medical instruments; Mice; Oxygen; Parameter sensitivity; Rodents; Sensitivity; Staphylococcus aureus; Staphylococcus aureus - drug effects; Staphylococcus aureus infections; Staphylococcus infections; Supplementation; Supplements; Tumor cells; Xylazine; Xylazine - pharmacology
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0134048

Infectious murine models greatly benefit from optical imaging using bioluminescent bacteria to non-invasively and repeatedly follow in vivo bacterial infection. In this context, one of the most critical parameters is the bioluminescence sensitivity to reliably detect the smallest number of bacteria. Another critical point is the anesthetic approaches that have been demonstrated to impact the bioluminescence flux emission in studies with luciferase-transfected tumor cells. However, this impact has never been assessed on bacteria bioluminescent models. To this end, we investigated the effects of four anesthesia protocols on the bioluminescence flux in a central venous catheter murine model (SKH1-hr(hr) mice) infected by a bioluminescent S. aureus Xen36 strain. Bioluminescence imaging was performed on mice anesthetized by either ketamine/xylazine (with or without oxygen supplementation), or isoflurane carried with air or oxygen. Total flux emission was determined in vivo daily for 3 days and ex vivo at the end of the study together with a CFU counting of the biofilm in the catheter. Bioluminescence flux differences appear between the different anesthetic protocols. Using a ketamine/xylazine anesthesia (with air), bacteria detection was impossible since the bioluminescence signal remains in the background signal. Mice anesthetized with isoflurane and oxygen led to a signal significantly higher to the background all along the kinetics. The use of isoflurane in air presents a bioluminescence signal similar to the use of ketamine/xylazine with oxygen. These data highlight the importance of oxygen to improve bioluminescence flux by bacteria with isoflurane as well as with ketamine/xylazine anesthetics. As a conclusion, we recommend the use of isoflurane anesthetic with oxygen to increase the bioluminescence sensitivity in this kind of study.